EPISODE · Jun 13, 2025 · 32 MIN
Kyrsten Sinema: Inside the Psychedelic Fast-Track for Veterans
from Divergent States · host Divergent States
A former U.S. Senator says the federal government is preparing to fast-track psychedelic medicines, especially for veterans with TBI, PTSD, addiction, and treatment-resistant depression.In this conversation, Kyrsten Sinema explains why the current administration is unusually aligned behind plant-based therapies, how Ibogaine and MDMA could move through the FDA faster than expected, and why small researchers, not Big Pharma, may end up shaping the field.We dig into:Ibogaine’s impact on Special Forces veteransWhy bipartisan support is real and why it’s strangeWhat “FDA fast-track” actually meansThe fight to secure Medicaid/Medicare + VA coverageHow cost + access could shift once CMS approves careThe threat of large companies burying breakthroughsWhy trauma + TBI may define the next decade of medicineSinema isn’t claiming everything is solved.She argues there’s a rare window — and it could close.Whether you’re hopeful or skeptical, you’ll walk away with a clearer view of the policy machinery behind psychedelic medicine.⏱️ Chapters:00:00 – Intro: Politics, Power, and Psychedelics 01:41 – Why Interview Sinema? Pushback & Intentions 02:21 – First Sponsor Tease & PS25 Plans 03:56 – Sinema Joins the Interview 04:18 – How Ibogaine Changed Her Perspective 06:49 – Senate Colleagues' Reactions 07:44 – Policy Progress & Bipartisan Allies 09:43 – Pharma Capture & Psychedelic Industry Risks 12:02 – Can Psychedelics Avoid Biotech Monopoly? 13:40 – Cost, Access, and Equity Concerns 14:44 – Ensuring Access for the Most Vulnerable 15:56 – State vs. Federal Models 17:00 – Federal Role in Decriminalization & Reform 17:20 – Regrets or Missed Legislative Opportunities? 18:43 – Sinema’s Continued Involvement 20:06 – Political Alignment vs. Policy Goals 20:17 – Restoring Trust in Institutions 21:55 – Five-Year Outlook for Psychedelic Medicine 23:10 – Final Reflections & Outro 23:41 – Bonus: Sinema on Psychedelic Science 2025 Panels 25:17 – Collaboration with VETS Foundation 25:53 – Closing Thanks & Conference Plans 28:49 – Outro Recap & Reflections 31:19 – Sponsors, Shulgin Legacy, and Fireside Project 32:10 – Next Episode Tease: Dr. Anne WagnerSend us Fan MailFiresideProject.orgDownload the app or text/call 62-FIRESIDEZendo ProjectOur listeners get 10% off the Zendo Project SIT Program with the code DIVERGENTS10Disclaimer: This post contains affiliate links. If you make a purchase, I may receive a commission at no extra cost to you.Support the showSpecial Thanks to our Macrodosers, Super D and Mike, and our Thumbprint Tier member, Angie on Patreon! https://linktr.ee/3L1T3Mod
What this episode covers
A former U.S. Senator says the federal government is preparing to fast-track psychedelic medicines, especially for veterans with TBI, PTSD, addiction, and treatment-resistant depression. In this conversation, Kyrsten Sinema explains why the current administration is unusually aligned behind plant-based therapies, how Ibogaine and MDMA could move through the FDA faster than expected, and why small researchers, not Big Pharma, may end up shaping the field. We dig into: Ibogaine’s impact on Spec...
NOW PLAYING
Kyrsten Sinema: Inside the Psychedelic Fast-Track for Veterans
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.